$RPRX

Royalty Pharma plc

Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY

RPRX chart

What traders are saying about $RPRX

Latest posts

Royalty Pharma plc news

Royalty Pharma plc key financials

USD2025202420232022
Revenue$2.38B$2.26B$2.35B$2.24B
Net income$770.9M$859.0M$1.13B$42.8M
Diluted EPS$1.78$1.91$2.53$0.10
Total assets (year end)$19.62B$18.22B$16.38B$16.81B
Cash and equivalents (year end)$618.7M$929.0M$477.0M$1.71B

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Royalty Pharma plc

Ticker
RPRX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
New York, NY
Incorporated in
United Kingdom
Fiscal year end
December 31
SEC CIK
1802768

Frequently asked questions

What exchange is Royalty Pharma plc listed on?

Royalty Pharma plc trades on the Nasdaq under the ticker symbol RPRX.

What industry is Royalty Pharma plc in?

Royalty Pharma plc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Royalty Pharma plc headquartered?

Royalty Pharma plc's business address on file with the SEC is in New York, NY.

When does Royalty Pharma plc's fiscal year end?

Royalty Pharma plc's fiscal year ends on December 31.

How much revenue did Royalty Pharma plc report?

Royalty Pharma plc reported $2.38B in revenue for calendar year 2025, according to its SEC filings.